Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
- DOI
- 10.7892/boris.145015
- Published
- 2020
- Container
- Not recorded
- Publisher
- University of Bern
- Open access
- no
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- supportingPublication license: A publication license was supplied: http://purl.org/coar/access_right/c_16ec. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7892/boris.145015,
title = {Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.},
author = {Chabriat, Hugues and Bassetti, Claudio L.A. and Marx, Ute and Audoli-Inthavong, Marie-Laure and Sors, Aurore and Lambert, Estelle and Wattez, Marine and Hermann, Dirk M},
year = {2020},
doi = {10.7892/boris.145015},
url = {https://doi.org/10.7892/boris.145015}
}RIS
TY - JOUR TI - Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial. AU - Chabriat, Hugues AU - Bassetti, Claudio L.A. AU - Marx, Ute AU - Audoli-Inthavong, Marie-Laure AU - Sors, Aurore AU - Lambert, Estelle AU - Wattez, Marine AU - Hermann, Dirk M PY - 2020 DO - 10.7892/boris.145015 UR - https://doi.org/10.7892/boris.145015 ER -
APA
Hugues, C., L.A., B. C., Ute, M., Marie-Laure, A., Aurore, S., Estelle, L., Marine, W., & M, H. D. (2020). Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.. https://doi.org/10.7892/boris.145015
Source records
- datacite · retrieved 2026-09-26T03:38:23.092Z